In pancreatic cancer, this is linked to Akt-regulation by galectin-3, which in turn modulates GSK-3β phosphorylation and β-catenin degradation by suppression of the β-catenin/Wnt signaling pathway [20]. The gene discussed is AKT1; the disease is pancreatic neoplasm.